Merck (MRK) Gains from Investment Securities (2016 - 2025)
Historic Gains from Investment Securities for Merck (MRK) over the last 17 years, with Q3 2025 value amounting to $51.0 million.
- Merck's Gains from Investment Securities rose 10557.99% to $51.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$292.0 million, marking a year-over-year increase of 7211.08%. This contributed to the annual value of -$510.0 million for FY2024, which is 4366.2% down from last year.
- According to the latest figures from Q3 2025, Merck's Gains from Investment Securities is $51.0 million, which was up 10557.99% from -$335.0 million recorded in Q2 2025.
- Over the past 5 years, Merck's Gains from Investment Securities peaked at $386.0 million during Q2 2024, and registered a low of -$914.0 million during Q3 2024.
- Moreover, its 5-year median value for Gains from Investment Securities was -$171.0 million (2021), whereas its average is -$177.1 million.
- Over the last 5 years, Merck's Gains from Investment Securities had its largest YoY gain of 29108.91% in 2024, and its largest YoY loss of 116279.07% in 2024.
- Over the past 5 years, Merck's Gains from Investment Securities (Quarter) stood at -$306.0 million in 2021, then surged by 56.86% to -$132.0 million in 2022, then crashed by 230.3% to -$436.0 million in 2023, then skyrocketed by 123.17% to $101.0 million in 2024, then plummeted by 49.5% to $51.0 million in 2025.
- Its Gains from Investment Securities stands at $51.0 million for Q3 2025, versus -$335.0 million for Q2 2025 and -$109.0 million for Q1 2025.